Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies
Hemangi B. Shah, Kenneth Smith, Edgar J. Scott II, Jason L. Larabee, Judith A. James, Jimmy D. Ballard, Mark L. Lang
Hemangi B. Shah, Kenneth Smith, Edgar J. Scott II, Jason L. Larabee, Judith A. James, Jimmy D. Ballard, Mark L. Lang
View: Text | PDF
Research Article Immunology Infectious disease

Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies

  • Text
  • PDF
Abstract

Clostridioides difficile is a leading cause of nosocomial infection responsible for significant morbidity and mortality with limited options for therapy. Secreted C. difficile toxin B (TcdB) is a major contributor to disease pathology, and select TcdB-specific Abs may protect against disease recurrence. However, the high frequency of recurrence suggests that the memory B cell response, essential for new Ab production following C. difficile reexposure, is insufficient. We therefore isolated TcdB-specific memory B cells from individuals with a history of C. difficile infection and performed single-cell deep sequencing of their Ab genes. Herein, we report that TcdB-specific memory B cell–encoded antibodies showed somatic hypermutation but displayed limited isotype class switch. Memory B cell–encoded mAb generated from the gene sequences revealed low to moderate affinity for TcdB and a limited ability to neutralize TcdB. These findings indicate that memory B cells are an important factor in C. difficile disease recurrence.

Authors

Hemangi B. Shah, Kenneth Smith, Edgar J. Scott II, Jason L. Larabee, Judith A. James, Jimmy D. Ballard, Mark L. Lang

×

Figure 10

CTD-specific Bmem encode nonneutralizing antibodies.

Options: View larger image (or click on image) Download as PowerPoint
CTD-specific Bmem encode nonneutralizing antibodies.
(A) Serum from CTD-...
(A) Serum from CTD-immunized rabbit diluted to 1:100 and mAbs from subjects 1008, 1009, and 1013 at a final concentration of 10 μg/mL mixed with media containing 0.23 nM TcdB1 were added to CHO cells to assess cell viability. (B) IgG from plasma of subjects 1008, 1009, and 1013 was depleted and tested in vitro for toxin neutralization capacity. The plasma with and without IgG were diluted 1:100 in media with 0.23 nM TcdB1. (C and D) As in A and B, respectively, except samples were mixed with media containing 0.25 nM TcdB2 and added to CHO cells to assess cell viability. Red dotted line represents CHO cell viability in the presence of media containing toxin alone. Duplicates from a single experiment are presented and are representative of at least 2 independent determinations. The data are represented by mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts